Radiogenomic markers enable risk stratification and inference
of mutational pathway states in head and neck cancer

J 2023

Radiogenomic markers enable risk stratification and inference of mutational pathway states in head and neck cancer

SPIELVOGEL, Clemens P, Stefan STOIBER, Laszlo PAPP, Denis KRAJNC, Marko GRAHOVAC et. al.

Základní údaje

Originální název

Radiogenomic markers enable risk stratification and inference of mutational pathway states in head and neck cancer

Autoři

SPIELVOGEL, Clemens P, Stefan STOIBER, Laszlo PAPP, Denis KRAJNC, Marko GRAHOVAC, Elisabeth GURNHOFER, Karolína TRACHTOVÁ (203 Česká republika, domácí), Vojtěch BYSTRÝ (203 Česká republika, domácí), Asha LEISSER, Bernhard JANK, Julia SCHNOELL, Lorenz KADLETZ, Gregor HEIDUSCHKA, Thomas BEYER, Marcus HACKER, Lukas KENNER (garant) a Alexander R HAUG

Vydání

European Journal of Nuclear Medicine and Molecular Imaging, NEW YORK, SPRINGER, 2023, 1619-7070

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30224 Radiology, nuclear medicine and medical imaging

Stát vydavatele

Spojené státy

Utajení

není předmětem státního či obchodního tajemství

Odkazy

URL

Impakt faktor

Impact factor: 9.100 v roce 2022

Kód RIV

RIV/00216224:14740/23:00133757

Organizační jednotka

Středoevropský technologický institut

DOI

http://dx.doi.org/10.1007/s00259-022-05973-9

UT WoS

000859613300002

Klíčová slova anglicky

Head and neck cancer; Biomarkers; Radiomics; Machine learning; Artificial intelligence; Cancer genomics

Štítky

CF BIOIT, CF GEN, rivok

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 15. 10. 2024 14:52, Ing. Martina Blahová

Anotace

V originále

Purpose Head and neck squamous cell carcinomas (HNSCCs) are a molecularly, histologically, and clinically heterogeneous set of tumors originating from the mucosal epithelium of the oral cavity, pharynx, and larynx. This heterogeneous nature of HNSCC is one of the main contributing factors to the lack of prognostic markers for personalized treatment. The aim of this study was to develop and identify multi-omics markers capable of improved risk stratification in this highly heterogeneous patient population.

Návaznosti

90267, velká výzkumná infrastruktura

Název: NCMG III

Citovat

SPIELVOGEL, Clemens P, Stefan STOIBER, Laszlo PAPP, Denis KRAJNC, Marko GRAHOVAC, Elisabeth GURNHOFER, Karolína TRACHTOVÁ, Vojtěch BYSTRÝ, Asha LEISSER, Bernhard JANK, Julia SCHNOELL, Lorenz KADLETZ, Gregor HEIDUSCHKA, Thomas BEYER, Marcus HACKER, Lukas KENNER a Alexander R HAUG. Radiogenomic markers enable risk stratification and inference of mutational pathway states in head and neck cancer. European Journal of Nuclear Medicine and Molecular Imaging. NEW YORK: SPRINGER, 2023, roč. 50, č. 2, s. 546-558. ISSN 1619-7070. Dostupné z: https://dx.doi.org/10.1007/s00259-022-05973-9.

@article{2383197,
   author = {Spielvogel, Clemens P and Stoiber, Stefan and Papp, Laszlo and Krajnc, Denis and Grahovac, Marko and Gurnhofer, Elisabeth and Trachtová, Karolína and Bystrý, Vojtěch and Leisser, Asha and Jank, Bernhard and Schnoell, Julia and Kadletz, Lorenz and Heiduschka, Gregor and Beyer, Thomas and Hacker, Marcus and Kenner, Lukas and Haug, Alexander R},
   article_location = {NEW YORK},
   article_number = {2},
   doi = {http://dx.doi.org/10.1007/s00259-022-05973-9},
   keywords = {Head and neck cancer; Biomarkers; Radiomics; Machine learning; Artificial intelligence; Cancer genomics},
   language = {eng},
   issn = {1619-7070},
   journal = {European Journal of Nuclear Medicine and Molecular Imaging},
   title = {Radiogenomic markers enable risk stratification and inference of mutational pathway states in head and neck cancer},
   url = {https://link.springer.com/article/10.1007/s00259-022-05973-9},
   volume = {50},
   year = {2023}
}

TY  - JOUR
ID  - 2383197
AU  - Spielvogel, Clemens P - Stoiber, Stefan - Papp, Laszlo - Krajnc, Denis - Grahovac, Marko - Gurnhofer, Elisabeth - Trachtová, Karolína - Bystrý, Vojtěch - Leisser, Asha - Jank, Bernhard - Schnoell, Julia - Kadletz, Lorenz - Heiduschka, Gregor - Beyer, Thomas - Hacker, Marcus - Kenner, Lukas - Haug, Alexander R
PY  - 2023
TI  - Radiogenomic markers enable risk stratification and inference of mutational pathway states in head and neck cancer
JF  - European Journal of Nuclear Medicine and Molecular Imaging
VL  - 50
IS  - 2
SP  - 546-558
EP  - 546-558
PB  - SPRINGER
SN  - 16197070
KW  - Head and neck cancer
KW  - Biomarkers
KW  - Radiomics
KW  - Machine learning
KW  - Artificial intelligence
KW  - Cancer genomics
UR  - https://link.springer.com/article/10.1007/s00259-022-05973-9
N2  - Purpose Head and neck squamous cell carcinomas (HNSCCs) are a molecularly, histologically, and clinically heterogeneous set of tumors originating from the mucosal epithelium of the oral cavity, pharynx, and larynx. This heterogeneous nature of HNSCC is one of the main contributing factors to the lack of prognostic markers for personalized treatment. The aim of this study was to develop and identify multi-omics markers capable of improved risk stratification in this highly heterogeneous patient population.
ER  -

SPIELVOGEL, Clemens P, Stefan STOIBER, Laszlo PAPP, Denis KRAJNC, Marko GRAHOVAC, Elisabeth GURNHOFER, Karolína TRACHTOVÁ, Vojtěch BYSTRÝ, Asha LEISSER, Bernhard JANK, Julia SCHNOELL, Lorenz KADLETZ, Gregor HEIDUSCHKA, Thomas BEYER, Marcus HACKER, Lukas KENNER a Alexander R HAUG. Radiogenomic markers enable risk stratification and inference of mutational pathway states in head and neck cancer. \textit{European Journal of Nuclear Medicine and Molecular Imaging}. NEW YORK: SPRINGER, 2023, roč.~50, č.~2, s.~546-558. ISSN~1619-7070. Dostupné z: https://dx.doi.org/10.1007/s00259-022-05973-9.

Podrobný výpis o publikaci